packageIbritumomabTiuxetan
ibritumomab tiuxetan
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Ibritumomab tiuxetan is a radioimmunotherapy drug, a monoclonal antibody radiopharmaceutical used to treat follicular lymphoma. It is an approved medication, though its European Union marketing authorisation has lapsed, so its use is now limited mainly to the United States.
Summary written by glm-5.3-flash from Wikidata Q635415 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | ibritumomab tiuxetan |
| ATC codes: | V10XX02 |
| DrugBank: | DB00078 |
| Wikidata: | Q635415 |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |